[ADCs/항체-약물 복합체] Antibody Drug Conjugates_ALB Materials - 코아사이언스

ANTIBODY DRUG CONJUGATES

Antibody-drug conjugates or ADCs are a new class of highly potent biopharmaceutical drugs designed as a targeted therapy for the treatment of people with cancer. ADCs are complex molecules composed of an antibody (a whole mAb or an antibody fragment such as a single-chain variable fragment [scFv]) linked, via a stable, chemical, linker with labile bonds, to a biological active cytotoxic (anticancer) payload or drug. Antibody Drug Conjugates are examples of bioconjugates and immunoconjugates.

• Drugs: MMAE, MMAF, DM1, DM4 and etc.
• Linkers: MC-Val-Cit-PAB-PNP, Fmoc-VC-PAB-PNP, SMCC, MMC and etc.
• Drug-linkers:DM1-SMCC, MC-Val-Cit-PAB-MMAE, MC-Val-Cit-PAB-MMAF, SuO-Val-Cit--PAB-MMAE and etc.

코아사이언스 coresciences ALB technology antibody drug conjugates ADCs ADC thechnology cytotoxin cytotoxic anticancer payload bioconjugates immunoconjugates targeted therapy linkers smart bomb 스마트폭탄 의약품 면역 항체 표적 치료제 개발 항암치료제 항체 약물 표적화 기술 세포독성물질 결합 항체 항암효과 화학의약품 small cehmicals 항체의약품 암세포 타깃 항체 항암 항체-약물 접합 항체 신약 항체시밀러 Antibody-Drug Conjugate 기술 ALB materials